Article Details

First Wave BioPharma Finalizes Selection of Adrulipase Microgranule Drug Delivery Formulation

Retrieved on: 2022-09-07 11:02:44

Tags for this article:

Click the tags to see associated articles and topics

First Wave BioPharma Finalizes Selection of Adrulipase Microgranule Drug Delivery Formulation. View article details on hiswai:

Excerpt

First Wave BioPharma expects to initiate Phase 2 trial investigating “optimized adrulipase” prior to year-end 2022. BOCA RATON, Fla., Sept.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up